SEC Form 4/A · accession 0001267602-15-000072
ALIMERA SCIENCES INC · ALIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
C. Daniel Myers
Officer — President and CEO · Director
Period of report
Apr 30, 2015
Accepted (ET)
Nov 16, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Apr 30, 2015 | A | 678 | $3.706 | A | 90,995 | D | |
| Common StockF2 | May 1, 2015 | S | 2,000 | $4.37 | D | 88,995 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- F2The Form 4 initially filed on May 4, 2015 inadvertently reported an incorrect number of shares acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan and thus the number of shares beneficially owned following the transaction was also incorrect.
- F3The Form 4 initially filed on May 4, 2015 inadvertently listed an incorrect price.
- F4The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2014.